Search for Clinical Trial Results

Sponsored By

Angioedemas, Hereditary - 67 Studies Found

Status Study
Completed Study Name: Pharmacokinetics of C1 Esterase Inhibitor in Hereditary Angioedema Subjects
Condition: Hereditary Angioedema
Date: 2007-02-07
Interventions: Drug: C1 esterase inhibitor [human] (C1INH-nf)
Completed Study Name: Open-Label C1 Esterase Inhibitor (C1INH-nf) for the Treatment of Acute Hereditary Angioedema (HAE) Attacks
Condition: Hereditary Angioedema
Date: 2007-02-21
Interventions: Biological: C1 esterase inhibitor [human] (C1INH-nf)
Completed Study Name: Open-Label C1 Esterase Inhibitor (C1INH-nf) for the Prevention of Acute Hereditary Angioedema (HAE) Attacks
Condition: Hereditary Angioedema
Date: 2007-04-17
Interventions: Biological: C1 esterase inhibitor [human] (C1INH-nf)
Completed Study Name: A Study to Evaluate the Clinical Efficacy and Safety of Subcutaneously Administered C1-esterase Inhibitor in the Prevention of Hereditary Angioedema
Condition: Hereditary Angioedema Types I and II
Date: 2013-07-29
Interventions:
  • Biological: Low-volume C1-esterase inhibitor
Recruiting Study Name: Safety of Ruconest in 2-13 Year Old Hereditary Angioedema (HAE) Patients
Condition: Hereditary Angioedema
Date: 2011-05-19
Interventions: Drug: rhC1INH Patients up to 84 kg will receive one i.v. injection of Ruconest at a dose of 50 U/kg. The
Completed Study Name: Safety and Efficacy Study of Repeated Doses of DX-88 (Ecallantide) to Treat Attacks of Hereditary Angioedema (HAE)
Condition: Hereditary Angioedema
Date: 2007-04-04
Interventions: Drug: ecallantide solution for SC injection, one 30 mg dose per HAE attack
Completed Study Name: A Study of Icatibant in Patients With Acute Attacks of Hereditary Angioedema (FAST-3)
Condition: Hereditary Angioedema
Date: 2009-06-02
Interventions:
  • Drug: Icatibant Single subcuta
Completed Study Name: Subcutaneous Treatment With Icatibant for Acute Attacks of Hereditary Angioedema (HAE)
Condition: Hereditary Angioedema
Date: 2007-07-12
Interventions:
  • Drug: Icatibant Icatibant: a s
Withdrawn Study Name: Study to Evaluate Ecallantide in Paediatric Patients With Acute Attacks of Hereditary Angioedema
Condition: Hereditary Angioedema
Date: 2010-12-02
Interventions: Biological: ecallantide 10 - 30mg subcutaneous injection.
Completed Study Name: CINRYZE for the Treatment of Hereditary Angioedema Attacks in Children Under the Age of 12
Condition: Hereditary Angioedema
Date: 2010-03-24
Interventions: Biological: CINRYZE Other Name: C1 inhibitor [human]
Next >>>